• No results found

University of Groningen Engineering Bacillus subtilis for Production of Antimalaria Artemisinin and Anticancer Paclitaxel Precursors Pramastya, Hegar

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Engineering Bacillus subtilis for Production of Antimalaria Artemisinin and Anticancer Paclitaxel Precursors Pramastya, Hegar"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Engineering Bacillus subtilis for Production of Antimalaria Artemisinin and Anticancer Paclitaxel Precursors

Pramastya, Hegar

DOI:

10.33612/diss.126860906

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Pramastya, H. (2020). Engineering Bacillus subtilis for Production of Antimalaria Artemisinin and Anticancer Paclitaxel Precursors. University of Groningen. https://doi.org/10.33612/diss.126860906

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Stellingen

Behorende bij het proefschrift

Engineering Bacillus subtilis for Production of Antimalaria

Artemisinin and Anticancer Paclitaxel Precursors

van Hegar Pramastya

1. Plasmid stability clearly affects the MEP pathway genes expression in B. subtilis, which eventually influences terpenoids production (this thesis)

2. Terpenoid bacterial cell factory requires multivariable optimization ranging from protein expression to medium components (this thesis).

3. More vector, promoter, and regulator tools are required to support fine tuning of gene expression benefiting higher production of secondary metabolites (this thesis). 4. Heterologous gene expression of a terpenoid pathway facilitates non-native

terpenoid production in microbes (this thesis).

5. Green fluorescent protein, now, is not only fused to a protein for studying its localization but also for increasing its expression as exemplified by amorphadiene synthase expression in B. subtilis (this thesis).

6. High fidelity DNA polymerase enables the construction of a large size gene cluster/ operon independent of restriction and ligation enzymes (this thesis).

7. It is probably the era where the smaller is the better: even a “factory” now has taken its shape in a form of bacteria.

8. Human brain has driven the world to a better place, but it is his heart that makes it beautiful and long lasting.

9. Everything is the cause of itself (Ralph Waldo Emerson)

10. The duty of the man who investigates the writings of scientists, if learning the truth is his goal, is to make himself an enemy of all that he reads, and ... attack it from every side. He should also suspect himself as he performs his critical examination of it, so that he may avoid falling into either prejudice or leniency (Ibn Al Haytham/ Alhazen)

11. The nobility of knowledge is such that, whoever it is attributed to, even in an insignificant amount, is joyful; and whoever it is withheld from, is distraught (Al Shafi’i)

Referenties

GERELATEERDE DOCUMENTEN

The research described in this thesis was carried out at the Department of Chemical and Pharmaceutical Biology (Groningen Research Institute of Pharmacy, University of

Thus, an alternative approach to produce these pharmaceuticals is microbial engineering, in which the synthetic pathway for the production of the target molecules from the

subtilis has 15 inherent enzymes, belonging to five terpenoid biosynthesis pathways: two terpenoid backbone biosynthesis upstream pathways (the mevalonate pathway and MEP pathway),

subtilis mntA (AAGAGGAGGAGAAAT).. Strategy for constructing the synthetic operons. The first gene, dxs, was cloned in the pHB201 plasmid using SpeI and BamHI restriction sites.

On these plasmids different subsets of MEP pathway genes were cloned and the genetic stability, level of gene expression and amount of C 30 carotenoids produced by.. the

High level production of amorphadiene using Bacillus subtilis as a terpenoid cell factory   . linearized by PCR using primer F2 while pDR111-gfpads using

subtilis overexpressing an endogenous MEP pathway are constructed to provide precursors for various downstream terpenoids, modulating the activities and expressions of enzymes in

Dus, wanneer gemodificeerde B.subtilis met expressie van endogene MEP-route worden geconstrueerd om te voorzien in precursors voor verschillende onderliggende terpenoïden, zal